CBD and CBG alter UVA-stressed melanocyte metabolism

Phytocannabinoids Regulate Lipid Metabolism in UVA-Irradiated Melanocytes.

European journal of pharmacology • • Highly Relevant
🤖

AI Summary

This cell study examined how the phytocannabinoids CBD and CBG, alone or together, affected cultured melanocytes before and after exposure to UVA radiation. The compounds entered the cells and were found mainly in cellular membranes. UVA disrupted redox balance, increased oxidative stress and lipid peroxidation, and changed membrane phospholipids, fatty acids, and phospholipase A2 activity. CBG and the CBD+CBG combination partially counteracted several of these changes, while CBD and CBG also influenced membrane surface properties.

The cannabinoids modified pathways involved in fatty-acid oxidation, endocannabinoid levels, and inflammatory lipid mediators. In UVA-exposed cells, they partially restored reduced levels of AEA, 2-AG, and PEA, decreased several pro-inflammatory mediators, and increased the anti-inflammatory mediator 15-d-PGJ2. They also altered expression of CB1, CB2, TRPV1, and PPARγ receptors. Overall, the abstract reports that phytocannabinoids partially restored redox balance and reduced inflammatory signaling in UVA-irradiated melanocytes. However, this is an in vitro study, so it cannot establish protection in human skin, prevention of melanoma, or clinical benefit; this is an abstract-based summary and does not assess the full text.

💡 Key Findings

1
UVA exposure disrupted redox balance and membrane lipid metabolism in cultured melanocytes, while CBG and CBD+CBG partially counteracted several of these cellular changes.
Moderate
50%
2
CBD and CBG modulated inflammatory lipid signaling by decreasing several pro-inflammatory mediators and increasing the anti-inflammatory mediator 15-d-PGJ2.
Moderate
50%
3
The phytocannabinoids partially reversed UVA-associated reductions in the endocannabinoids AEA, 2-AG, and PEA and altered expression of CB1, CB2, TRPV1, and PPARγ receptors.
Moderate
45%
4
Because the work was conducted in cultured cells, it does not establish a protective or melanoma-preventing effect in people.
High
90%

📄 Original Abstract

Melanocytes are specialized skin cells that produce melanin. Under conditions of metabolic disturbances caused by UVA radiation, melanocytes may undergo neoplastic transformation, potentially leading to melanoma. This study evaluated the effects of phytocannabinoids, cannabidiol (CBD), cannabigerol (CBG), and their combination (CBD+CBG) in control cells and following UVA irradiation. Both compounds penetrated cells and localized primarily within cellular membranes. UVA exposure altered their intracellular distribution and disrupted redox homeostasis by decreasing total antioxidant status and increasing oxidative stress, as evidenced by elevated levels of lipid peroxidation products, including malondialdehyde. Administration of CBG or CBD+CBG partially prevented these changes. UVA irradiation also altered phospholipid composition and polyunsaturated fatty acids, and increased phospholipase A2 activity, which was partially counteracted by CBD and CBG. Although phytocannabinoids modulated membrane surface charge by altering sialic acid levels. Phytocannabinoids influenced fatty acid oxidation pathways mediated by cyclooxygenases. They partially reversed the UVA-induced reduction in endocannabinoids (AEA, 2-AG, PEA) and modulated eicosanoid profiles by decreasing pro-inflammatory mediators (PGE2, PGD2, 5-HETE, 12-HETE) while increasing the anti-inflammatory mediator, 15-d-PGJ2. These changes were accompanied by altered expression of membrane receptors. UVA exposure increased the expression of CB1, CB2, TRPV1, and PPARγ receptors. CBG upregulated all of these receptors, whereas CBD and CBD+CBG selectively modulated TRPV1 and PPARγ expression. In conclusion, phytocannabinoids partially restored redox balance and reduced inflammatory signaling, thereby normalizing membrane composition and cellular signaling in UVA-exposed melanocytes. These findings suggest a regulatory role for phytocannabinoids in melanocyte responses to UVA exposure, with potential implications for metabolic processes involved in neoplastic transformation.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.